Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
- CAD | -.--% |
|
+6.67% | -11.11% |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 18.12.19 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 18.12.19 |
William Jackson
BRD | Director/Board Member | - | 01.01.14 |
Andrew Lindzon
BRD | Director/Board Member | 63 | 18.12.19 |
Director/Board Member | 50 | 18.12.19 | |
Joshua Herman
BRD | Director/Board Member | - | 18.12.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 418 564 269 | 412 444 735 ( 98,54 %) | 0 | 98,54 % |
Unternehmenskontakt
Revive Therapeutics Ltd.
The Canadian Venture Building 82 Richmond Street East
M5C 1P1, Toronto
+888-901-0036
http://www.revivethera.com![Straße Revive Therapeutics Ltd(RVV)](https://cdn.zonebourse.com/static/address/18313352.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
+16.13% | 122 Mrd. | |
+19.65% | 115 Mrd. | |
+21.22% | 26.64 Mrd. | |
-23.84% | 19.91 Mrd. | |
-17.47% | 16.32 Mrd. | |
-45.95% | 15.52 Mrd. | |
-19.28% | 15.49 Mrd. | |
+63.81% | 14.83 Mrd. | |
+1.94% | 13.67 Mrd. |
- Börse
- Aktien
- A2AP4F Aktie
- RVV Aktie
- Unternehmen Revive Therapeutics Ltd